NCT07195188

Brief Summary

The goal of this clinical trial is to learn if an education program can help lower anxiety and improve treatment follow-up in adults with type 2 diabetes. The main questions it aims to answer are: Does attending the education program lower anxiety levels? Does it help people better follow their diabetes treatment plan? Researchers will compare two groups: Education group: Participants who attend the program. Control group: Participants who do not attend the program. Participants will: Be randomly assigned to either the education group or the control group. Attend four weekly sessions, each lasting two hours, over one month (education group only). Complete surveys before and after the program, including the Beck Anxiety Scale (to measure anxiety) and the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment (to measure treatment follow-up).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2024

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 26, 2025

Completed
Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

28 days

First QC Date

September 11, 2025

Last Update Submit

September 25, 2025

Conditions

Keywords

Type 2 Diabetes, Insulin Therapy, Game-Based Education, Treatment Adherence, Anxiety, Randomized Controlled Study, Nursing Education, Patient Education

Outcome Measures

Primary Outcomes (1)

  • Treatment Compliance Levels

    For Treatment Compliance: The level of compliance among individuals undergoing diabetes-to-diabetes treatment was determined using the Patient Compliance Scale for Type 2 Diabetes Treatment, a 30-item, five-point Likert-type scale. A low total score indicates high patient compliance. For Anxiety: "Anxiety levels of individuals with diabetes were determined using the Beck Anxiety Scale (BAS), a 21-item, four-point Likert-type self-report scale. Higher scores indicate more severe anxiety.

    Pre-intervention and Post-intervention (After 1 Month of Training)

Study Arms (2)

Game-Based Education

EXPERIMENTAL

Arm Description: Participants in this group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, conducted over one month. The sessions aim to improve diabetes knowledge, reduce anxiety, and increase adherence to insulin therapy.

Behavioral: "Let's Learn Diabetes" Game-Based Education

Traditional Diabetes Education

ACTIVE COMPARATOR

Participants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.

Behavioral: Traditional Diabetes Education

Interventions

Participants in the experimental group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, over one month. The intervention is designed to improve diabetes knowledge, reduce anxiety, and enhance treatment adherence among patients with Type 2 Diabetes Mellitus on insulin therapy.

Game-Based Education

Participants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.

Traditional Diabetes Education

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Age at diagnosis of diabetes is recent or less than 1 year.
  • Being on insulin therapy for more than three months.
  • Mental or psychological comorbidity.
  • Not within the target age range, under 40 years or over 65 years.
  • Refusing to participate in the research.
  • Not attending one or more of the four training sessions during the research process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uşak Eğitim Ve Araştırma Hastanesi

Uşak, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes MellitusTreatment Adherence and ComplianceAnxiety Disorders

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHealth BehaviorBehaviorMental Disorders

Study Officials

  • Gönül düzgün, phd

    Izmir Tinaztepe University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: two groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant profesor

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 26, 2025

Study Start

April 5, 2024

Primary Completion

May 3, 2024

Study Completion

November 30, 2024

Last Updated

September 26, 2025

Record last verified: 2025-09

Locations